Navigation Links
3SBio Inc. to Present at 30th Annual J.P. Morgan Healthcare Conference
Date:1/4/2012

SHENYANG, China, Jan. 4, 2012 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced Dr. Jing Lou, 3SBio's chief executive officer will present at the 30th Annual J.P. Morgan Healthcare Conference in San Francisco on January 11, 2012 at 1:30pm pacific time.

Audio webcasts with accompanying slides will be available live and archived at www.3sbio.com under the investor relations section until February 11, 2012.

About 3SBio Inc.3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China.  Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.  With headquarters and MP-certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 800 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX". Please see www.3SBio.com for more information.Investor ContactsBo Tan

Tom FolinsbeeChief Financial OfficerDirector of Investor Relations3SBio Inc.

3SBio Inc.Tel: + 86 24 2581-1820

Tel: + 852 8191-6991ir@3SBio.com

ir@3SBio.com
'/>"/>

SOURCE 3SBio Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. 3SBio Inc. Schedules Unaudited Third Quarter 2011 Results
2. 3SBio Inc. to Hold 2011 Annual General Meeting on September 20, 2011
3. 3SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results
4. 3SBio Inc. Schedules Unaudited Second Quarter 2011 Results
5. 3SBio Inc. Announces SFDA Approval of High-Dose EPIAO
6. 3SBio Announces Conversion of Isotechnika Debenture
7. 3SBio Inc. Schedules Third Quarter 2010 Unaudited Financial Results
8. 3SBio Announces Partial Conversion of Isotechnika Debenture
9. 3SBio Announces Investor Conference Schedule
10. 3SBio and Isotechnika Pharma Announce Strategic Partnership to Develop and Commercialize Voclosporin in China
11. 3SBio Inc. Announces Results of Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2020)... Mo. (PRWEB) , ... June 19, 2020 , ... ... end hunger in individuals diagnosed with food allergies and celiac disease announced the first ... Allergy. , This webinar is scheduled for Friday, June 19, 2020, from 11:00, ...
(Date:6/19/2020)... , ... June 19, 2020 ... ... of its cross-platform campaign 'Clinical Trials.' This campaign showcases the innovative medical ... these studies, thereby advancing knowledge and disease treatment. This public awareness campaign ...
(Date:6/19/2020)... , ... June 18, 2020 , ... World Allergy Organization ... emphasize the importance of maintaining regular care of allergies and asthma during the COVID-19 ... world caused by infection with a new strain of coronavirus (SARS-CoV-2). Patients with symptoms ...
Breaking Medicine Technology:
(Date:6/28/2020)... ... June 26, 2020 , ... ... is to provide high-quality, intensive education and training that prepares graduates for professional ... as new member of the Board of Trustees. , Ms. Williams currently serves ...
(Date:6/28/2020)... , ... June 26, 2020 , ... ... essential workers and the general public. As a supplier of top-quality masks, sanitizers ... direct source for PPE equipment. President Priya Agarwal observed, “All of our masks ...
(Date:6/28/2020)... ... , ... World Allergy Organization (WAO), serving its membership of ... to July 4, 2020, to the importance of continued allergy self-care during the ... is a disease spreading around the world caused by infection with a new ...
(Date:6/24/2020)... NEWPORT BEACH, Calif. (PRWEB) , ... June 24, 2020 , ... ... that it has launched a new website at http://www.evolvednaturals.com The newly launched ... assortment of broad-spectrum CBD oils , and a comprehensive line of skincare ...
(Date:6/24/2020)... ... June 24, 2020 , ... SPH Analytics , ... Physician Hospital Organization (PHO) has successfully deployed SPH’s Population Care™ all-payer population health ... value-based care. Use of Population Care is benefitting more than 77,000 patients covered ...
Breaking Medicine News(10 mins):